Lantus, the new long-acting "peakless" insulin
You'll soon be able to prescribe Lantus, the new long-acting "peakless" insulin.
It was approved last year...but Aventis had to postpone the launch until they had an adequate supply.
Lantus is an insulin analog called insulin glargine. It differs from human insulin by 3 amino acids.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote